Novoprotein Scientific Inc. (SHA:688137)

China · Delayed Price · Currency is CNY

42.19

+1.57 (3.87%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Biotechnology	127.56M	153.19M	264.55M	341.90M	179.84M
Biotechnology Growth	-16.73%	-42.09%	-22.62%	90.11%	399.79%
Total	127.56M	153.19M	264.55M	341.90M	179.84M
Total Growth	-16.73%	-42.09%	-22.62%	90.11%	399.79%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	122.04M	-	-	-	133.77M
China Growth	-	-	-	-	350.15%
Overseas sales	5.36M	-	-	-	45.97M
Overseas sales Growth	-	-	-	-	684.71%
Total	127.40M	-	-	-	179.73M
Total Growth	-	-	-	-	405.23%

Source: S&P Global Market Intelligence.